Epithalon
Epitalon (L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-glycine; AEDG peptide)
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Vladimir Khavinson that activates telomerase in human somatic cells and modulates pineal gland melatonin synthesis; the strongest mechanistic data are in vitro telomerase and telomere studies, while human clinical evidence remains limited to small Russian programs summarized in a 2025 review (PMID 12937682, PMID 15455129, PMID 40141333).
Last updated: 2026-03-10
Safety Summary
Adverse event reporting for epithalon is sparse. The retinitis pigmentosa clinical program (162 patients) reported no side effects, and a 15-year follow-up study with epithalamin showed no adverse events (PMID 40141333). However, the 2025 review emphasizes that critical short- and long-term toxicity, genotoxicity, carcinogenic potential, and drug interaction studies remain missing. The FDA flags immunogenicity, aggregation, and peptide-impurity risks for compounded epithalon products. The side effects listed above are primarily sourced from vendor safety pages and community reports, not from rigorous clinical trial adverse event monitoring (PMID 40141333, EXA-a51a5d54d7ba).
Known Side Effects
common
uncommon
uncommon
uncommon
uncommon
unknown
Who Should NOT Use This
Theoretical caution: epithalon activates telomerase, a hallmark of cancer cells. However, existing animal data actually show inhibition of leukemia (6-fold), decreased mammary tumors, and no increase in total spontaneous tumor incidence. The 2025 review states carcinogenic potential is insufficiently characterized. This remains a theoretical concern rather than a proven contraindication (PMID 12937682, PMID 40141333).
No safety data available for pregnant or breastfeeding women. Standard precaution for any unstudied compound.
No safety data available for pediatric use.
The FDA specifically flags epithalon for immunogenicity risk due to potential aggregation and peptide-related impurities. Immune responses to peptides can be serious.
Epithalon modulates immune function including T-cell differentiation, thymic endocrine activity, and IL-2 expression. These immunomodulatory effects could theoretically exacerbate autoimmune conditions, though no direct evidence of harm exists in the source set (PMID 14743608, PMID 12420072).
Talk to Your Doctor
Before considering Epithalon, discuss it with your healthcare provider. Ask about potential interactions with your current medications, whether it is appropriate for your health conditions, and what monitoring may be needed.
Sources: [1-25]
Evidence Assessment
Tier 4 fits the current source set: multiple well-replicated in vitro studies demonstrating telomerase activation and telomere elongation (PMID 12937682, PMID 15455129), extensive animal lifespan and tumor studies across mice, rats, and Drosophila (PMID 18856211, PMID 10977918), primate endocrine data (PMID 11550036), and ex vivo human lymphocyte chromatin work (PMID 15085253). Direct human evidence is limited to a small sublingual melatonin study and a retinitis pigmentosa program summarized in a 2025 review, with important ambiguity about whether some human trials used epithalamin rather than synthetic epithalon. No registered ClinicalTrials.gov development program exists and no FDA-approved product is available (PMID 40141333).
1Overview of Epitalon -- Highly Bioactive Pineal Tetrapeptide with Promising PropertiesPMID 40141333
Araj S, Sobesky L, et al. - International Journal of Molecular Sciences (2025) - Systematic review0
Comprehensive review covering 25+ years of cell, animal, and human data. Summarizes retinitis pigmentosa trial (162 patients), sublingual melatonin study (75 women), and extensive preclinical work. Emphasizes unresolved safety and mechanism questions, stereoisomer issues, and stability limitations.
Limitations: Secondary synthesis. Much underlying literature is from a single research group and small or older studies. Some cited clinical data used epithalamin, not synthetic epithalon.
2Epithalon peptide induces telomerase activity and telomere elongation in human somatic cellsPMID 12937682
Khavinson V Kh, Bondarev I E, Butyugov A A - Bulletin of Experimental Biology and Medicine (2003) - In vitro0
Induced telomerase activity and telomere elongation in human fetal fibroblasts. Average 33.3% telomere elongation in lymphocytes.
Limitations: Cell-study evidence only; no clinical endpoint.
3Peptide promotes overcoming of the division limit in human somatic cellPMID 15455129
Khavinson V Kh, Bondarev I E, Butyugov A A, Smirnova T D - Bulletin of Experimental Biology and Medicine (2004) - In vitro0
Epithalon-treated human fetal fibroblasts continued dividing after passage 44 while controls stopped at passage 34, representing approximately 10 additional population doublings.
Limitations: In vitro model from a single research lineage.
4Regulatory effect of Epithalon on production of melatonin and cortisol in old monkeysPMID 11550036
Goncharova N D, Khavinson V Kh, Lapin B A - Bulletin of Experimental Biology and Medicine (2001) - Animal0
In old female rhesus monkeys, epithalon stimulated evening melatonin production and normalized cortisol circadian rhythms.
Limitations: Animal endocrine model; not a human clinical trial.
5Effects of peptides on proliferative activity of retinal and pigmented epithelial cellsPMID 12937684
Khavinson V Kh, Zemchikhina V N, Trofimova S V, Malinin V V - Bulletin of Experimental Biology and Medicine (2003) - In vitro0
Epithalon stimulated proliferation of retinal and pigmented epithelial cells in culture, with optimal effects at 10 ng/mL concentration.
Limitations: Retinal cell-culture evidence only.
6Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNAPMID 22117547
Fedoreyeva L I, Kireev I I, Khavinson V Kh, Vanyushin B F - Biochemistry (Biokhimiia) (2011) - In vitro0
Fluorescently labeled epithalon entered HeLa-cell nuclei and showed sequence-selective DNA interactions, preferentially binding CNG-containing sequences and discriminating cytosine methylation status.
Limitations: HeLa cell and in vitro nucleic-acid binding study.
7Effect of Ala-Glu-Asp-Gly peptide on life span and development of spontaneous tumors in female rats exposed to different illumination regimesPMID 18856211
Vinogradova I A, Bukalev A V, Zabezhinski M A, et al. - Bulletin of Experimental Biology and Medicine (2007) - Animal0
Under natural northwestern Russia light, epithalon extended maximum lifespan by 95 days and inhibited tumor development. Under constant light, maximum lifespan increased by 24 days. No effect under standard 12h light/dark cycles. Initial decreased physical activity in first 3 months normalized.
Limitations: Rat model with environment-dependent results.
8Studies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technologyPMID 12360356
Anisimov S V, Boheler K R, Khavinson V Kh, Anisimov V N - Bulletin of Experimental Biology and Medicine (2002) - Animal0
Epithalon modulated 98 gene clones (max 6.61-fold activation) in mouse heart. Combined with Vilon, 144 clones were affected.
Limitations: Mouse transcriptional study without clinical translation.
9Gene expression in mouse brain: effects of Epithalon and melatoninPMID 15723138
Anisimov S V, Khavinson V Kh, Anisimov V N - Not specified in abstract (2004) - Animal0
Epithalon modified 22 transcripts in mouse brain, sharing 6 with melatonin. Target genes related to cell cycle, apoptosis, and nucleic acid transport.
Limitations: Mouse gene expression study.
10Effects of short peptides on lymphocyte chromatin in senile subjectsPMID 15085253
Khavinson V Kh, Lezhava T A, Malinin V V - Bulletin of Experimental Biology and Medicine (2004) - Ex vivo human0
Lymphocytes from subjects aged 75-88 showed activation of ribosome genes and chromatin decondensation (deheterochromatinization) after epithalon exposure.
Limitations: Ex vivo work; sample size not stated.
11Effect of Epithalon on the incidence of chromosome aberrations in senescence-accelerated micePMID 12360351
Anisimov V N, Khavinson V Kh, et al. - Bulletin of Experimental Biology and Medicine (2002) - Animal0
Epithalon decreased chromosome aberrations in bone marrow: SAMP-1 by 20%, SAMR-1 by 30.1%, SHR by 17.9% (p<0.05).
Limitations: Mouse bone marrow study.
12Effects of pineal peptide preparation Epithalamin and Epithalon on free-radical processes in humans and animalsPMID 10977918
Anisimov V N, Arutjunyan A V, Khavinson V Kh - Neuro Endocrinology Letters (2001) - Animal / In vitro0
Epithalon showed antioxidant biological activity 1000-fold greater than epithalamin in Drosophila models. Extended lifespan of D. melanogaster by up to 16%.
Limitations: Drosophila and in vitro models.
13Comitogenic activity of synthetic peptides on thymocyte proliferationPMID 12420072
Khavinson V Kh, et al. - Bulletin of Experimental Biology and Medicine (2002) - In vitro0
Epithalon showed comitogenic effect on thymocytes when co-treated with concavalin A or rIL-1beta. Less potent than Vilon. Did not activate neutral sphingomyelinase.
Limitations: Murine thymocyte in vitro model.
14Ultrastructural signs of enhanced pineal gland functional activity after Epithalon treatment in irradiated ratsPMID 11329090
Khavinson V Kh, et al. - Bulletin of Experimental Biology and Medicine (2001) - Animal0
Epithalon partially preserved pineal gland structure from gamma-irradiation damage and facilitated recovery, particularly through restoration of mitochondrial ultrastructure.
Limitations: Rat irradiation model.
15Tissue-specific stimulation of subcortical brain structure growth by EpithalonPMID 11713572
Khavinson V Kh, et al. - Bulletin of Experimental Biology and Medicine (2001) - Animal0
Epithalon showed tissue-specific stimulation of subcortical brain structure growth, distinguishing it from cortex-specific Cortagen.
Limitations: Animal brain morphology study.
16Sex- and age-related differences in reactive oxygen species generationPMID 11687853
Not captured in source extract - Bulletin of Experimental Biology and Medicine (2001) - Animal0
Epithalon affected reactive oxygen species generation in subcellular fractions with sex- and age-dependent effects.
Limitations: Animal subcellular fraction study.
17Regulatory effects of Epitalon on circadian genes, senescence markers, and sirtuinsPMID 39742404
Not captured in source extract - Not captured in source extract (2024) - In vitro / Review0
Epithalon regulates Cry2, AANAT, ASMT, CLOCK; reduces p16 (1.56-1.92x), p21 (2.22-2.44x), p53; modulates TERF-1, prohibitin, SIRT1, SIRT6.
Limitations: Cell culture data; mechanism extrapolation to humans not established.
18Threefold increase in nocturnal melatonin in old rhesus monkeysPMID 12096440
Khavinson V Kh, et al. - Not captured in source extract (2002) - Animal0
Old rhesus monkeys showed threefold increase in nocturnal melatonin peaks after epithalon treatment. Also showed postponed vision loss in Campbell rats.
Limitations: Animal model.
19Chronic epithalamin treatment restored T-cell differentiation in aging micePMID 14743608
Not captured in source extract - Not captured in source extract (2003) - Animal0
Restored T-cell differentiation patterns with improved CD4+/CD8+ ratios and increased thymic endocrine function in aging mice.
Limitations: Mouse immune model; Russian-language primary source.
20Restoration of circadian rhythms of thymic serum factorPMID 15490729
Not captured in source extract - Not captured in source extract (2004) - Animal0
Epithalon restored circadian rhythms of thymic serum factor.
Limitations: Animal model; Russian-language primary source.
21Protective effect of Epithalon on chromosome aberrations in lymphocytes from tuberculosis patientsPMID 24323970
Not captured in source extract - Not captured in source extract (2013) - Ex vivo human0
Pronounced protective effect on chromosome aberrations in lymphocyte cultures from tuberculosis patients.
Limitations: Ex vivo study; Russian-language primary source.
22Protective effect of Epithalon on genome parameters in hypertrophic cardiomyopathy patientsPMID 24423684
Not captured in source extract - Not captured in source extract (2013) - Ex vivo human0
Most effective protective action for normalizing genome parameters in lymphocytes from hypertrophic cardiomyopathy patients.
Limitations: Ex vivo study; Russian-language primary source.
23Melatonin and epitalon corrected hypothalamic-pituitary-gonadal axis impairmentsPMID 28976150
Not captured in source extract - Not captured in source extract (2017) - Animal0
Melatonin and epithalon together corrected hypothalamic-pituitary-gonadal axis impairments in animal models of premature reproductive aging under unfavorable lighting.
Limitations: Animal model; Russian-language primary source.
24Epithalon lessened heavy metal effects on chromosome fragile sites in lymphocytesPMID 18830022
Not captured in source extract - Not captured in source extract (2008) - Ex vivo human0
Epithalon exhibited antimutagenic characteristics when co-administered with zinc, cobalt, and nickel in lymphocyte cultures.
Limitations: Ex vivo study.
25Effect of Epithalon on cathepsin activity in rat tissuesPMID 17152724
Not captured in source extract - Not captured in source extract (2006) - Animal0
Decreased cathepsin B and D activity in rat liver and kidneys.
Limitations: Single rat tissue study; Russian-language primary source.